Diabetes

Organisation: forskargrupp

Forskningsområden

Ämnesklassifikation (UKÄ)

  • Endokrinologi och diabetes

Forskning

This project aims to develop incretin therapy as a glucose-reducing strategy in type 2 diabetes (T2D). Its particular focus is to understand the mechanisms of incretin therapy and to optimize its clinical positioning. This mission is achieved by an interdisciplinary approach with complementary studies in subjects with T2D, healthy volunteers and experimental animals.

Senaste forskningsoutput

Tura, A., Pacini, G., Yamada, Y., Seino, Y. & Bo Ahrén, 2019, I : American journal of physiology. Regulatory, integrative and comparative physiology. 316, 1, s. R27-R37

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Bo Ahrén, Atkin, S. L., Charpentier, G., Warren, M. L., Wilding, J. P. H., Birch, S., Holst, A. G. & Leiter, L. A., 2018 sep 1, I : Diabetes, Obesity and Metabolism. 20, 9, s. 2210-2219 10 s.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Bo Ahrén, 2018 aug 12, I : Journal of Diabetes Investigation.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Visa alla (35)